Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery

Anesth Analg. 2006 Jun;102(6):1902-3. doi: 10.1213/01.ANE.0000215133.89323.61.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acenocoumarol / administration & dosage
  • Acenocoumarol / adverse effects*
  • Administration, Oral
  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Cesarean Section*
  • Factor VIIa / therapeutic use*
  • Female
  • Heart Valve Prosthesis
  • Humans
  • Pregnancy
  • Recombinant Proteins / therapeutic use
  • Uterine Hemorrhage / chemically induced
  • Uterine Hemorrhage / drug therapy*

Substances

  • Anticoagulants
  • Recombinant Proteins
  • Factor VIIa
  • Acenocoumarol